The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Insomnia | Benzodiazepine Hypnotics | Nonbenzodiazepine Hypnotics | Sedative Antihistamines and Other Nonbenzodiazepine Psychoactive Drugs With Hypnotic Properties | Other Hypnotics | Dual Orexin Receptor Antagonists | General Conclusions | Bibliography

Excerpt

Insomnia is generally defined as a difficulty initiating or maintaining sleep or a poor quality of sleep. Insomnia may be primary or secondary to other conditions such as depression, anxiety, mania, or substance abuse. Primary insomnia appears to be uncommon relative to secondary insomnia. Various population surveys have found self-reported rates of symptoms of insomnia in about a third of adults. About 10% of the U.S. population report having experienced symptoms of chronic insomnia that may have lasted for many years. However a smaller percentage of patients have insomnia with significant daytime impairment. According to the “NIH State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults Statement” (2005), perhaps 10% of the population has clinically significant insomnia if the criterion of daytime impairment is included in the criteria. According to a 2014 survey by the National Sleep Foundation, about 17% of the population use a hypnotic at least once a week and 10% of the population use a some kind of sleeping aid on a daily basis (National Sleep Foundation 2014). Women and older adults appear to be the demographic groups at greatest risk for significant insomnia, but of course transient insomnia can affect anyone.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).